Monash IVF has pleased investors with news that it expects a solid rise in first half profit after an increase in patient treatments.
Shares in Monash IVF have soared after the company delivered news that its first half profit would jump by a quarter.
Shareholders at the company's annual meeting heard that it had increased the number of assisted reproductive treatments by more than 18 per cent in the four months to October 15.
Monash had also lifted its market share, with business particularly strong in Victoria, South Australia and Queensland.
The group now expects its first half net profit for 2015/16 will rise by 25 per cent above the $10.98 million recorded in the previous corresponding period.
"Monash IVF has enjoyed a strong rebound in patient treatments and associated revenues in Q1FY16," chief executive James Thiedeman said.
Mr Thiedeman said Monash was continuing to look for acquisitions to add to its existing fertility businesses in Australia and Malaysia.
Shares in the company were 26 cents, or 18.3 per cent, higher at $1.68 at 1529 AEDT.